PET (Position Emission Tomography) is a nuclear medicine technique for evaluating biomedical and physiological processes in the body.
The combination with CT scan adds anatomic information.
68 Ga FAPI PET/CT targets cancer associated fibroblast activation protein inhibitors. It has shown to be superior to FDG in a number of different types of cancers especially signet ring carcinoma of stomach and colon, serous adenocarcinoma of ovary, primary pancreatic cancer, biliary cancer, soft tissue sarcoma and renal cell carcinoma.
